RxNorm Semantic Concepts Index - 134
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "134".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1340181 | Smilax regelii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1340183 | chondrodendron tomentosum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1340185 | Lilium lancifolium whole flowering extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13402 | 2-haloacid dehalogenase | Designated preferred name (PT) | NO | |
| RxCUI: 13402 | 2-haloacid dehalogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 1341 | Batrachotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 1341 | Batrachotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 13410 | Exalamide | Designated preferred name (PT) | NO | |
| RxCUI: 13410 | Exalamide | Full form of descriptor (FN) | NO | |
| RxCUI: 13410 | Exalamide | Designated preferred name (PT) | NO | |
| RxCUI: 13410 | Exalamide | Full form of descriptor (FN) | NO | |
| RxCUI: 1341384 | common wormwood root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1341384 | common wormwood root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1341385 | Teucrium marum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1341385 | Teucrium marum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1341817 | Mentha piperita diagnostic allergen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1341817 | Mentha piperita diagnostic allergen extract | Full form of descriptor (FN) | NO | |
| RxCUI: 1341817 | Mentha piperita diagnostic allergen extract | Designated preferred name (PT) | NO | |
| RxCUI: 13422 | 2-hydroxy-3-oxo-adipate synthase | Designated preferred name (PT) | NO | |
| RxCUI: 13422 | 2-hydroxy-3-oxo-adipate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13422 | 2-hydroxy-3-oxo-adipate synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 1342455 | Eriodictyon californicum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342487 | Caulophyllum thalictroides root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1342488 | Lycosa tarantula preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342489 | Fucus serratus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342490 | Dysphania ambrosioides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342490 | Dysphania ambrosioides whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1342491 | Ballota foetida extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342492 | Yucca filamentosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342492 | Yucca filamentosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1342493 | Glycyrrhiza uralensis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342649 | Adonis vernalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1342649 | Adonis vernalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1343346 | comfrey root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1343597 | Cypripedium parvifolum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134381 | Carnitine palmitoyltransferase II | Designated preferred name (PT) | NO | |
| RxCUI: 134381 | Carnitine palmitoyltransferase II | Full form of descriptor (FN) | NO | |
| RxCUI: 1343912 | Candida torresii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1344 | Live attenuated Mycobacterium bovis antigen-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 1344 | Live attenuated Mycobacterium bovis antigen-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1344 | Live attenuated Mycobacterium bovis antigen-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 134404 | Urofollitropin | Full form of descriptor (FN) | NO | |
| RxCUI: 134404 | Urofollitropin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134404 | Urofollitropin | Designated preferred name (PT) | NO | |
| RxCUI: 134404 | Urofollitropin | Full form of descriptor (FN) | NO | |
| RxCUI: 134404 | Urofollitropin | Designated preferred name (PT) | NO | |
| RxCUI: 134413 | pentosan polysulfate sodium | Designated preferred name (PT) | YES | |
| RxCUI: 134413 | pentosan polysulfate sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 134413 | pentosan polysulfate sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 134413 | pentosan polysulfate sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 134413 | pentosan polysulfate sodium | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 13442 | 2-hydroxybutyrate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 13442 | 2-hydroxybutyrate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 13442 | 2-hydroxybutyrate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 13442 | 2-hydroxybutyrate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 134422 | magnesium valproate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 134426 | Androstenediol | Designated preferred name (PT) | NO | |
| RxCUI: 134426 | Androstenediol | Full form of descriptor (FN) | NO | |
| RxCUI: 1344626 | Lupinus albus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1344641 | Convallaria majalis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1344642 | influenza A-B virus immunoserum rabbit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1344643 | Sambucus nigra flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1344644 | Elymus repens top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1344662 | Delamanid | Designated preferred name (PT) | NO | |
| RxCUI: 1344662 | Delamanid | Full form of descriptor (FN) | NO | |
| RxCUI: 1344662 | Delamanid | Designated preferred name (PT) | NO | |
| RxCUI: 1344662 | Delamanid | Full form of descriptor (FN) | NO | |
| RxCUI: 134472 | Amide synthase | Designated preferred name (PT) | NO | |
| RxCUI: 134472 | Amide synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 134472 | Amide synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134472 | Amide synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1344798 | Lilium lancifolium flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1344799 | quinhydrone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134485 | Carbon-carbon lyase | Designated preferred name (PT) | NO | |
| RxCUI: 134485 | Carbon-carbon lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 134486 | Carbon-oxygen lyase | Designated preferred name (PT) | NO | |
| RxCUI: 134486 | Carbon-oxygen lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 134487 | Carbon-nitrogen lyase | Designated preferred name (PT) | NO | |
| RxCUI: 134487 | Carbon-nitrogen lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 134489 | Phosphorus-oxygen lyase | Designated preferred name (PT) | NO | |
| RxCUI: 134489 | Phosphorus-oxygen lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 1345 | BCR-ABL protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1345 | BCR-ABL protein | Designated preferred name (PT) | NO | |
| RxCUI: 1345 | BCR-ABL protein | Full form of descriptor (FN) | NO | |
| RxCUI: 134514 | Transformylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134514 | Transformylase | Designated preferred name (PT) | NO | |
| RxCUI: 134514 | Transformylase | Full form of descriptor (FN) | NO | |
| RxCUI: 134516 | Carbamoyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134516 | Carbamoyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 134516 | Carbamoyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 134517 | Carboxyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134517 | Carboxyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 134517 | Carboxyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 13452 | 2-hydroxyestrone | Designated preferred name (PT) | NO | |
| RxCUI: 13452 | 2-hydroxyestrone | Full form of descriptor (FN) | NO | |
| RxCUI: 134520 | Aminoacyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 134520 | Aminoacyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 134526 | Viracept | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 134527 | Nelfinavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 134527 | Nelfinavir | Designated preferred name (PT) | YES | |
| RxCUI: 134527 | Nelfinavir | Full form of descriptor (FN) | YES | |
| RxCUI: 134527 | Nelfinavir | Designated preferred name (PT) | YES | |
| RxCUI: 134527 | Nelfinavir | Full form of descriptor (FN) | YES | |
| RxCUI: 134547 | Bendamustine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 134547 | Bendamustine | Designated preferred name (PT) | YES | |
| RxCUI: 134547 | Bendamustine | Full form of descriptor (FN) | YES | |
| RxCUI: 134547 | Bendamustine | Designated preferred name (PT) | YES | |
| RxCUI: 134547 | Bendamustine | Full form of descriptor (FN) | YES | |
| RxCUI: 1345677 | Rumex crispus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1345678 | Galium aparine whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1345678 | Galium aparine whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1345679 | northern house mosquito preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1345679 | northern house mosquito preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134568 | bentoquatam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 134568 | bentoquatam | Designated preferred name (PT) | YES | |
| RxCUI: 134568 | bentoquatam | Full form of descriptor (FN) | YES | |
| RxCUI: 134568 | bentoquatam | Designated preferred name (PT) | YES | |
| RxCUI: 134568 | bentoquatam | Full form of descriptor (FN) | YES | |
| RxCUI: 1345680 | Lilium lancifolium bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1345681 | Jacobaea maritima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1345681 | Jacobaea maritima whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1345682 | human breast tumor cell | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134585 | Poly levo lactic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134585 | Poly levo lactic acid | Designated preferred name (PT) | NO | |
| RxCUI: 134585 | Poly levo lactic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 13459 | Hydroxyethyl valine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13459 | Hydroxyethyl valine | Designated preferred name (PT) | NO | |
| RxCUI: 13459 | Hydroxyethyl valine | Full form of descriptor (FN) | NO | |
| RxCUI: 13461 | 2-hydroxyglutarate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 13461 | 2-hydroxyglutarate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 134615 | brimonidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 134615 | brimonidine | Designated preferred name (PT) | YES | |
| RxCUI: 134615 | brimonidine | Full form of descriptor (FN) | YES | |
| RxCUI: 134615 | brimonidine | Designated preferred name (PT) | YES | |
| RxCUI: 134615 | brimonidine | Full form of descriptor (FN) | YES | |
| RxCUI: 134659 | Citrate lyase ligase | Designated preferred name (PT) | NO | |
| RxCUI: 134659 | Citrate lyase ligase | Full form of descriptor (FN) | NO | |
| RxCUI: 134659 | Citrate lyase ligase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134659 | Citrate lyase ligase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1346616 | Caltha palustris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1346616 | Caltha palustris whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1346617 | oriental cockroach preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1346617 | oriental cockroach preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1346618 | Galphimia glauca flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1346619 | Geranium maculatum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134687 | Ferric-chelate reductase | Designated preferred name (PT) | NO | |
| RxCUI: 134687 | Ferric-chelate reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 1347 | Beclometasone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1347 | Beclometasone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 1347 | Beclometasone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1347 | Beclometasone-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1347 | Beclometasone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 1347 | Beclometasone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 1347 | Beclometasone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 134748 | Rasagiline | Full form of descriptor (FN) | YES | |
| RxCUI: 134748 | Rasagiline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 134748 | Rasagiline | Designated preferred name (PT) | YES | |
| RxCUI: 134748 | Rasagiline | Full form of descriptor (FN) | YES | |
| RxCUI: 134748 | Rasagiline | Designated preferred name (PT) | YES | |
| RxCUI: 1347557 | Ambrosia artemisiifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1347557 | Ambrosia artemisiifolia whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1347559 | bowfin preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1347560 | Berberis aquifolium root bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1347560 | Berberis aquifolium root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1347561 | Onosmodium virginianum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1347563 | Melilotus officinalis top | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1347563 | Melilotus officinalis top | Full form of descriptor (FN) | NO | |
| RxCUI: 1347563 | Melilotus officinalis top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1347563 | Melilotus officinalis top | Designated preferred name (PT) | NO | |
| RxCUI: 1347564 | Euphorbia hirta whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1347564 | Euphorbia hirta whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 134774 | Remeron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 134789 | 7-aminoflunitrazepam | Designated preferred name (PT) | NO | |
| RxCUI: 134789 | 7-aminoflunitrazepam | Full form of descriptor (FN) | NO | |
| RxCUI: 1348 | Beclometasone dipropionate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1348 | Beclometasone dipropionate | Full form of descriptor (FN) | YES | |
| RxCUI: 1348 | Beclometasone dipropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1348 | Beclometasone dipropionate | Designated preferred name (PT) | YES | |
| RxCUI: 134801 | 4-methyleneglutamate--ammonia ligase | Designated preferred name (PT) | NO | |
| RxCUI: 134801 | 4-methyleneglutamate--ammonia ligase | Full form of descriptor (FN) | NO | |
| RxCUI: 134802 | Naropin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 134839 | Desmethylastemizole | Designated preferred name (PT) | NO | |
| RxCUI: 134839 | Desmethylastemizole | Full form of descriptor (FN) | NO | |
| RxCUI: 1348449 | forget-me-not extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1348449 | forget-me-not extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1348450 | Ailanthus altissima flowering twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1348451 | Asclepias curassavica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1348452 | Impatiens glandulifera flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1348454 | Aconitum ferox root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1348455 | Taenia solium preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134847 | Scytalidium aspartic proteinase B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134847 | Scytalidium aspartic proteinase B | Designated preferred name (PT) | NO | |
| RxCUI: 134847 | Scytalidium aspartic proteinase B | Full form of descriptor (FN) | NO | |
| RxCUI: 134860 | Cerebyx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 134895 | Dostinex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 134906 | Pranlukast | Designated preferred name (PT) | NO | |
| RxCUI: 134906 | Pranlukast | Full form of descriptor (FN) | NO | |
| RxCUI: 134912 | PVA dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 134912 | PVA dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 134912 | PVA dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 134920 | Maxitrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 134923 | Ecadotril | Designated preferred name (PT) | NO | |
| RxCUI: 134923 | Ecadotril | Full form of descriptor (FN) | NO | |
| RxCUI: 1349278 | metenkefalin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 134928 | Alpha-1-antitrypsin isoform S | Designated preferred name (PT) | NO | |
| RxCUI: 134928 | Alpha-1-antitrypsin isoform S | Full form of descriptor (FN) | NO | |
| RxCUI: 134933 | omoconazole mononitrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 134933 | omoconazole mononitrate | Designated preferred name (PT) | NO | |
| RxCUI: 134933 | omoconazole mononitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 134954 | Alkylglycerophosphate 2-O-acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 134954 | Alkylglycerophosphate 2-O-acetyltransferase | Full form of descriptor (FN) | NO |